SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000819050-20-000043
Filing Date
2020-03-18
Accepted
2020-03-18 16:49:23
Documents
78
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a20191231-10k.htm   iXBRL 10-K 1749658
2 EXHIBIT 21.1 a20191231ex211.htm EX-21.1 11727
3 EXHIBIT 23.1 a20191231ex231.htm EX-23.1 14654
4 EXHIBIT 31.1 a20191231ex311.htm EX-31.1 13069
5 EXHIBIT 31.2 a20191231ex312.htm EX-31.2 12728
6 EXHIBIT 32.1 a20191231ex321.htm EX-32.1 15948
  Complete submission text file 0000819050-20-000043.txt   8296489

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20191231.xsd EX-101.SCH 55080
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20191231_cal.xml EX-101.CAL 82711
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20191231_def.xml EX-101.DEF 278758
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20191231_lab.xml EX-101.LAB 770166
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20191231_pre.xml EX-101.PRE 460442
56 EXTRACTED XBRL INSTANCE DOCUMENT a20191231-10k_htm.xml XML 1389256
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21088 | Film No.: 20725207
SIC: 2836 Biological Products, (No Diagnostic Substances)